Toward Efficient Trials in Colorectal Cancer: The ARCAD Clinical Trials Program-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toward Efficient Trials in Colorectal Cancer: The ARCAD Clinical Trials Program

Published:2010-02-01 Issue:4 Volume:28 Page:527-530
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

de Gramont Aimery¹,Haller Daniel G.²,Sargent Daniel J.³,Tabernero Josep⁴,Matheson Alastair⁵,Schilsky Richard L.⁶

Affiliation:

1. Hôpital Saint Antoine, Paris, France

2. Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA

3. Mayo Clinic, Cancer Center Statistics, Rochester, MN

4. Vall d'Hebron University Hospital, Medical Oncology Service, Barcelona, Spain

5. Foundation ARCAD, Paris, France

6. University of Chicago, Biological Sciences Division, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.25.2544

Reference35 articles.

1. Personalizing Cancer Care: American Society of Clinical Oncology Presidential Address 2009

2. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.

3. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

4. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis;European Journal of Cancer;2024-08

2. Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A);European Journal of Surgical Oncology;2024-06

3. Diagnostic Test for Realized Missingness in Mixed-type Data;Sankhya B;2023-12-20

4. ARCAD-Asia initiative: leveraging yesterday’s data for tomorrow;ESMO Gastrointestinal Oncology;2023-12

5. Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database;Cancers;2023-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3